(Q45258212)

11 December 2017

title

Dramatic improvement in Down syndrome-associated cognitive impairment with donepezil (English)

1 reference

11 December 2017

main subject

cognitive dysfunction

1 reference

Tatsuro Kondoh

1

1 reference

11 December 2017

Nagisa Amamoto

2

1 reference

11 December 2017

Tomoki Doi

3

1 reference

11 December 2017

Hitomi Hamada

4

1 reference

11 December 2017

Yoji Ogawa

5

1 reference

11 December 2017

Mikiro Nakashima

6

1 reference

11 December 2017

Hitoshi Sasaki

7

1 reference

11 December 2017

Katsuyo Aikawa

8

1 reference

11 December 2017

Tatsuhiko Tanaka

9

1 reference

11 December 2017

Mizue Aoki

10

1 reference

11 December 2017

Junji Harada

11

1 reference

11 December 2017

Hiroyuki Moriuchi

12

1 reference

11 December 2017

language of work or name

English

0 references

publication date

8 February 2005

1 reference

Annals of Pharmacotherapy

11 December 2017

published in

1 reference

11 December 2017

volume

39

1 reference

11 December 2017

issue

3

1 reference

11 December 2017

page(s)

563-566

1 reference

11 December 2017

1 reference

Abnormalities of the nucleus basalis in Down's syndrome

21 January 2018

1 reference

[3H]vesamicol binding in human brain cholinergic deficiency disorders

21 January 2018

1 reference

Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome

21 January 2018

1 reference

Donepezil for Down's syndrome

21 January 2018

1 reference

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease--pilot study.

21 January 2018

1 reference

Down syndrome and Alzheimer disease: response to donepezil

21 January 2018

1 reference

Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study

21 January 2018

1 reference

Donepezil use in the treatment of dementia associated with Down syndrome

21 January 2018

1 reference

Cognitive decline in Down syndrome.

21 January 2018

1 reference

Effects of Donepezil on Cognitive Functioning in Down Syndrome

21 January 2018

1 reference

Donepezil use in Down syndrome

21 January 2018

1 reference

Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population

21 January 2018

1 reference

The dementia scale for Down's syndrome.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1E427

1 reference

11 December 2017

1 reference